1. Home
  2. BCLI vs VS Comparison

BCLI vs VS Comparison

Compare BCLI & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • VS
  • Stock Information
  • Founded
  • BCLI 2000
  • VS 2013
  • Country
  • BCLI United States
  • VS United States
  • Employees
  • BCLI N/A
  • VS N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • VS EDP Services
  • Sector
  • BCLI Health Care
  • VS Technology
  • Exchange
  • BCLI Nasdaq
  • VS Nasdaq
  • Market Cap
  • BCLI 9.8M
  • VS 10.1M
  • IPO Year
  • BCLI N/A
  • VS N/A
  • Fundamental
  • Price
  • BCLI $1.16
  • VS N/A
  • Analyst Decision
  • BCLI Strong Buy
  • VS Hold
  • Analyst Count
  • BCLI 1
  • VS 1
  • Target Price
  • BCLI $30.00
  • VS $2.00
  • AVG Volume (30 Days)
  • BCLI 412.8K
  • VS 59.7K
  • Earning Date
  • BCLI 08-13-2025
  • VS 08-13-2025
  • Dividend Yield
  • BCLI N/A
  • VS N/A
  • EPS Growth
  • BCLI N/A
  • VS N/A
  • EPS
  • BCLI N/A
  • VS N/A
  • Revenue
  • BCLI N/A
  • VS $230,132.00
  • Revenue This Year
  • BCLI N/A
  • VS $3,459.21
  • Revenue Next Year
  • BCLI N/A
  • VS N/A
  • P/E Ratio
  • BCLI N/A
  • VS N/A
  • Revenue Growth
  • BCLI N/A
  • VS 64.71
  • 52 Week Low
  • BCLI $0.72
  • VS $1.00
  • 52 Week High
  • BCLI $6.45
  • VS $9.59
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 49.98
  • VS 59.13
  • Support Level
  • BCLI $1.02
  • VS $2.25
  • Resistance Level
  • BCLI $1.32
  • VS $2.44
  • Average True Range (ATR)
  • BCLI 0.09
  • VS 0.22
  • MACD
  • BCLI -0.00
  • VS 0.01
  • Stochastic Oscillator
  • BCLI 46.67
  • VS 68.77

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

Share on Social Networks: